Challenging delivery of VLHL NS plasminogen activator inhibitor-1 by osmotic pumps in diabetic mouse: A case report

Por JANKUN, JERZY
Publicado em 2012

Bleeding diathesis is associated with an A15T heterozygous mutation in exon 2 of the plasminogen activator inhibitor type 1

Por JANKUN, JERZY, SKRZYPCZAK-JANKUN, EWA
Publicado em 2010

Application of Long-Acting VLHL PAI-1 during Sutureless Partial Nephrectomy in Mice Reduces Bleeding

Por Shahrour, Khaled, Keck, Rick, Jankun, Jerzy
Publicado no Biomed Res Int (2015)

Comparison between the clot-protecting activity of a mutant plasminogen activator inhibitor-1 with a very long half-life and 6-aminocaproic acid

Por KINDELL, DANIEL GLENN, KECK, RICK WAYNE, JANKUN, JERZY
Publicado no Exp Ther Med (2015)

Synergistic anticancer activity of biologicals from green and black tea on DU 145 human prostate cancer cells

Por Kobalka, Andrew J., Keck, Rick W., Jankun, Jerzy
Publicado no Cent Eur J Immunol (2015)

Analysis of the anticancer activity of curcuminoids, thiotryptophan and 4-phenoxyphenol derivatives

Por PARSAI, SHIREEN, KECK, RICK, SKRZYPCZAK-JANKUN, EWA, JANKUN, JERZY
Publicado em 2014

Isolation and characterization of serum albumin from Camelus dromedarius

Por MALIK, AJAMALUDDIN, AL-SENAIDY, ABDULRAHMAN, SKRZYPCZAK-JANKUN, EWA, JANKUN, JERZY
Publicado em 2013

Effects of chlorhexidine, essential oils and herbal medicines (Salvia, Chamomile, Calendula) on human fibroblast in vitro

Por Wyganowska-Swiatkowska, Marzena, Urbaniak, Paulina, Szkaradkiewicz, Anna, Jankun, Jerzy, Kotwicka, Malgorzata
Publicado no Cent Eur J Immunol (2016)

Enamel matrix proteins exhibit growth factor activity: A review of evidence at the cellular and molecular levels

Por WYGANOWSKA-ŚWIĄTKOWSKA, MARZENA, URBANIAK, PAULINA, NOHAWICA, MICHAŁ MAREK, KOTWICKA, MAŁGORZATA, JANKUN, JERZY
Publicado no Exp Ther Med (2015)

Proteolysis is the most fundamental property of malignancy and its inhibition may be used therapeutically (Review)

Por Wyganowska-Świątkowska, Marzena, Tarnowski, Mateusz, Murtagh, Daniel, Skrzypczak-Jankun, Ewa, Jankun, Jerzy
Publicado no Int J Mol Med (2019)

Can components of the plasminogen activation system predict the outcome of kidney transplants?

Por Jankun, Jerzy, Khan, Omar A., Mostafa, Hesham I., Sindhwani, puneet, Skrzypczak-Jankun, Ewa
Publicado no Cent Eur J Immunol (2018)

Can EGCG Alleviate Symptoms of Down Syndrome by Altering Proteolytic Activity?

Por Wyganowska-Świątkowska, Marzena, Matthews-Kozanecka, Maja, Matthews-Brzozowska, Teresa, Skrzypczak-Jankun, Ewa, Jankun, Jerzy
Publicado no Int J Mol Sci (2018)

The concentration of 12-lipoxygenase in platelet rich plasma as an indication of cancer of the prostate

Por Piotrowska, Małgorzata, Szefel, Jarosław, Skrzypczak-Jankun, Ewa, Łysiak-Szydłowska, Wiesława, Szajewski, Mariusz, Aleksandrowicz-Wrona, Ewa, Jankun, Jerzy
Publicado em 2013

Evaluation of 12-Lipoxygenase (12-LOX) and Plasminogen Activator Inhibitor 1 (PAI-1) as Prognostic Markers in Prostate Cancer

Por Gondek, Tomasz, Szajewski, Mariusz, Szefel, Jarosław, Aleksandrowicz-Wrona, Ewa, Skrzypczak-Jankun, Ewa, Jankun, Jerzy, Lysiak-Szydlowska, Wieslawa
Publicado em 2014

Platelet 12-lipoxygenase and stem cells in Barrett’s esophagus

Por JAŒKIEWICZ, KAZIMIERZ, IŻYCKA-ŒWIESZEWSKA, EWA, JANIAK, MARIA, ŁYSIAK-SZYDŁOWSKA, WIESŁAWA, ADRYCH, KRYSTIAN, REINARTZ, JEANNETTE, JANKUN, JERZY, SKRZYPCZAK-JANKUN, EWA
Publicado em 2010

Formulation and characterization of EGCG for the treatment of superficial bladder cancer

Por Dettlaff, Katarzyna, Stawny, Maciej, Ogrodowczyk, Magdalena, Jelińska, Anna, Bednarski, Waldemar, Wątróbska-Świetlikowska, Dorota, Keck, Rick W., Khan, Omar A., Mostafa, Ibrahim H., Jankun, Jerzy
Publicado no Int J Mol Med (2017)